Toxicologie

Applications Neuroleptic agent related structurally to thiothixene. Antipsychotic; neuroleptic agent; dopamine receptor antagonist.
References Nielsen, et al.: Acta Pharmacol. Toxicol., 32, 363 (1973), Post, M.L., et al.: Nature, 256, 342 (1975), Peuch, et al.: Neuropharmacology, 20, 1279 (1981),

Applications Candesartan Cilexetil-d11 is the labeled analogue of Candesartan Cilexetil (C175580), is an ester prodrug; hydrolized in vivo to the active carboxylic acid. Used in treatment of congestive heart failure. Antihypertensive.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Shibouta, Y., et al.: J. Pharmacol. Exp. Ther., 266, 114 (1993), Ogihara, T., et al.: Clin. Ther., 16, 74 (1994)

Applications Atorvastatin Derivative

Impurity Olmesartan Medoxomil EP Impurity D
Applications Olmesartan medoxomil intermediate.
References Birkenhager, W., et al.: J. Hypertens, 17, 873 (1999), Whittaker, A., et al.: Br. J. Cardiol., 12, 125 (2005),

Stability Moisture Sensitive
Applications Fensulfothion Oxon Sulfone is a metabolite of the insecticide fensulfonthion (F265490), an inhibitor of cholinesterase activity.
References Solly, S.R.B., et al.: New. Zea. J. Agri. Res., 14, 88 (1971); Hansch, C., et al.: Biochem. Toxicol. Insectic. Proc., 33 (1970);

Impurity Ezetimibe Tetrahydropyran Impurity
Applications Ezetimibe (E975000) tetrahydropyran impurity.

Applications Atorvastatin impurity. Atorvastatin Methyl Ester
References Graul, A., et al.: Drugs Future, 22, 956 (1997),

Stability Light Sensitive, Temperature Sensitive
Applications A metabolite of all-trans Retinoic acid (R250200).
References Idres, N., et al.: Cancer Res., 61, 700 (2001), Taimi, M., et al.: J. Biol. Chem., 279, 77 (2004), Vermot, J., et al.: Science, 308, 563 (2005),

Applications Isotope labelled Bisphenol A β-D-Glucuronide is the glucuronide conjugate and metabolite of bisphenol A (B519495), an monomer used for policarbonate and epoxy resins.
References Zalko, D., et al.: Drug Metab. Dispos., 26, 28 (1998), Matthews, J., et al.: Chem. Res. Toxico., 14, 149 (2001), Kinjo, J., et al.: Biol. Pharm. Bull., 27, 185 (2004), Murata, M., et al.: Biochemistry, 43, 2569 (2004),

Applications It inhibits PDGFR tyrosine kinase with IC50=83nM. It is useful for the treatment of inflammation and as an anti-proliferative agent. Dual action VEGFR & Raf inhibitor.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Leuner, C., et al.: Eur. J. Pharm. Biopharm., 50, 47 (2000),

Applications Labelled xanthine oxidase inhibitor; decreases uric acid production. Used in treatment of hyperuricemia and chronic gout. Antiurolithic.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Benezra, S.A., et al.: Anal. Profiles Drug Subs., 7, 1, (1978), Dalbeth, N., et al.: Rheumatology, 44, 1090 (2005), Dinarello, C., et al.: J. Exp. Med., 201, 1355 (2005),

Applications Valifenalate is used in antibacterial compositions and method for controlling of plant disease with improved effect, fungicides preparation and phytosanitary treatments with fungicides.
References Gonnzalez-Alvarez, M., et al.: Food Chem., 131 826 (2012); Ogawa, M., et al.: PCT Int. Appl. (2016), WO 2016194971 A1 20161208

Applications Hexazinone is a herbicide. It functions by inhibiting photosynthesis and thus is a nonselective herbicide. Hexazinone is a pervasive groundwater contaminant, due to its high water solubility.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Kennedy, K., et al.: Weed Sci., 58, 317 (2010); Yanase, D., et al.: Pes. Biochem. Physio., 44, 60 (1992); Johnson, J., et al.: Tree Physio., 8, 371 (1991)

Applications A metabolite of Mianserin.
References Begg, E., et al.: Br. J. Clin. Pharmacol., 27, 445 (1989), Tybring, G., et al.: Ther. Drug Monit., 17, 516 (1995), Namera, A., et al.: J. Anal. Toxicol. 22, 396 (1998), van Nederkassel, A., et al.: J. Pharm. Biomed. Anal., 32, 233 (2003),

Applications Labelled racemic analogue of Ruxolitinib (R702000). Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.
References Shilling, A.D. et al.: Drug Metab. Disp., 38, 2023 (2010); Mesa, R.A.: IDrugs, 13, 394 (2010); Campas-Moya, C.: Drugs Fut., 35, 457 (2010);

Applications Labelled analogue of Pimozide, a D2 dopamine receptor antagonist. Pimozide binds with high affinity to the cloned 5-HT7 receptor. Pimozide is also a Ca2+ channel antagonist. Pimozide is used as an antipsychotic.
References Liu, J., et al.: Br. J. Pharmacol., 126, 245 (1999); Richelson, E., et al.: Life Sci., 68, 29 (2000); Santi, C., et al.: J. Neurosci., 22, 396 (2002); Mariot, P., et al.: J. Biol. Chem., 277, 10824 (2002); Nikonenko, I., et al.: Mol. Pharmacol., 68, 84 (2005);